Gewu Biotechnology

Gewu Biotechnology is a Shanghai-based synthetic biology company that specializes in the development of microbial cell factories for the production of high-value natural products. The company integrates computational enzyme design, metabolic pathway engineering, and high-throughput screening to optimize the biosynthesis of bioactive compounds. Their primary product portfolio includes ergothioneine and sialic acid, which are marketed for use in the cosmetics, food, and healthcare industries. By utilizing sustainable fermentation technology, Gewu Biotechnology provides a high-purity, cost-effective alternative to traditional chemical synthesis and natural extraction methods. The firm is backed by prominent venture capital investors and continues to expand its pipeline into complex oligosaccharides and specialized peptides.